Huntingtin

Huntingtin (HTT) is a large (350 kDa) protein essential for embryonic development and is involved in a variety of cellular functions, such as vesicular transport, endocytosis, transcription regulation and autophagy. Mutation in the associated gene — IT15 — results in an expansion of the polyQ tract found within the N-terminal region of the perspective protein. Such pathological growth, which surpasses the treshold of 36 glutamine residues, may lead to the development of Huntington disease (HD). The mutation becomes fully penetrant at ≥40 glutamine residues ^[1]. Mutant huntingtin (mHTT) is prone to aggregation. Yet, despite its ubiquitous expression, mHTT affects primarily the GABAergic medium spiny neurons of striatum and to a lesser extent the neurons of cerebral cortex ^[2].

Function

Since the discovery of HTT and its relevance to HD, efforts have been made to understand the physiological functions of wild-type huntingtin. However, an integrative understanding of its biological functions is still lacking. Many studies suggest that HTT is essential for cell survival and thereby its loss of function caused by the mutation is source for the neurodegeneration. Although it does, up to a certain degree, add to the disease phenotype, it is now generally believed that the main source of the disease is not the loss of its physiological functions, but the gain of function associated with the polyQ expansion.

Huntingtin and Embryonic Development

The crucial role of HTT for embryonic development has been shown using mouse knock-out (KO) models, in which homozygous KO mice die at day 8.5 and don't emerge the nervous system. ^[3] Furthermore, HTT was shown to play a key role in neurulation homotypic interactions of neuroepithelial cells, thereby providing more evidence on its importace for development of the nervous system.

Huntingtin and Transcription Regulation

HTT is mostly cytoplasmic. However, it can be aslo observed in the nucleus, as HTT comprises nuclear localization sequence in its NH2 terminus ^[4]. Its nuclear localization implies for its role in transcription regulation. An example of a well described target gene of HTT-mediated transcription regulation is the brain derived nerve growth factor (BDNF) ^[5]. However, there are more transcription factors described to interact with mHTT, as their interaction may lead to transcription dysregulation. Thanks to its abnormal structure, mHTT supresses the expression of PGC1-α — a transcription factor responsible for the regulation of many mitochondrial genes ^[6].

Huntingtin as a Scaffold Protein

Wild-type HTT is well known for its scaffolding function. It interacts with β-tubulin and binds to microtubules. Besides, it interacts with the dynein/dynactin complex, thereby regulating vesicular transport ^[7]. Furthermore, HTT has been shown to localize to spindle poles during mitosis, regulating spindle orientation in mouse neuronal cells^[8]. On the other hand, the abnormal scaffolding function for molecular motors operated via mHTT results in abrupted axonal transport. That leads to inefficient distribution of mitochondria within nerve cells, causing low ^[9]

Huntingtin Protein and Autophagy

Structure

HTT is a 3144 amino acids comprising protein, which possesses the polyglutamine chain at the amino-terminal region. It also contains multiple consesnsus sequences called HEAT (huntingtin, elongation factor 3, protein phosphatase 2A, and TOR1 (target of rapamycin)) repeats. These HEAT repeats are very important for protein-protein interactions, of which HTT has plentiful. HEAT repeats consist of helix-turn-helix motifs, which are packed into a compact form of a superhelix hydrophobic core able to resist dissociation upon proteolytic cleavage ^[10]. The presence of HEAT repeats enables HTT to participate in endocytosis-related trafficking, as clathrin and COPI (coat protein complex I) coatomer contain HEAT repeats as well ^[11].

Pathology

The general consensus is that the toxicity originates from the gain of function of mHTT, as the polyQ solely could still stretch and let to the development of neurological symptoms in mouse models ^[12][13][14]. However, the contribution of loss of function of the wild-type HTT cannot be abandoned, as wild-type HTT inactivation or deletion also leads to neurodegeneration ^[15][16]. As mentioned above, patients with mHTT develop HD. HD is an autosomal dominant neurodegenerative disorder characterized by behavioral, cognitive and motor dysfunctions. Although HD mostly affects middle-aged people, the age of onset is inversely correlated with the length of the polyQ tract. Very large expansion can even lead to juvenile and in rare cases infantile forms of the disease ^[17].

Huntingtin Protein Impairs Autophagy

There are two major pathways that secure the degradation of intracellular proteins. The ubiquitin-proteasome system, which serve to degrade wild-type HTT, and autophagy, which seems to be more important for the degradation of the expanded mutant forms as well as dysfunctional organelles ^[18]. Wild-type HTT seems to act as a scaffold for many parts of the autophagic machinery. The C-terminal part of HTT was found to have similar structure to Atg11, a yeast scaffolding protein associated with autophagy. Moreover, HTT was shown to interact with human homolog proteins, such as ULK1 (Unc-51 like autophagy activating kinase; homolog of yeast Atg1) and SQSTM1/p62 (homolog of yeast Atg19), which interact with Atg11 ^[19]. In mammals, the induction of autophagy depends on the ULK1-Atg13-FIP2000 complex. This complex is for most of the time inhibited by mTORC1-mediated phosphorylation. Furthermore, an exclusive complex with HTT can be formed. This complex does not lead to the inhibition of ULK1 and promotes the initiation of autophagy ^[20]. However, ULK1 has reduced affinity to mHTT and thereby reamins more inactive and bound to mTOR ^[21].

References

1. ↑ Vonsattel JP, DiFiglia M. Huntington disease. J Neuropathol Exp Neurol. 1998 May;57(5):369-84. doi:, 10.1097/00005072-199805000-00001. PMID:9596408 doi:http://dx.doi.org/10.1097/00005072-199805000-00001
2. ↑ Guedes-Dias P, Pinho BR, Soares TR, de Proenca J, Duchen MR, Oliveira JM. Mitochondrial dynamics and quality control in Huntington's disease. Neurobiol Dis. 2016 Jun;90:51-7. doi: 10.1016/j.nbd.2015.09.008. Epub 2015 Sep, 24. PMID:26388396 doi:http://dx.doi.org/10.1016/j.nbd.2015.09.008
3. ↑ Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet. 1995 Oct;11(2):155-63. doi: 10.1038/ng1095-155. PMID:7550343 doi:http://dx.doi.org/10.1038/ng1095-155
4. ↑ Desmond CR, Atwal RS, Xia J, Truant R. Identification of a karyopherin beta1/beta2 proline-tyrosine nuclear localization signal in huntingtin protein. J Biol Chem. 2012 Nov 16;287(47):39626-33. doi: 10.1074/jbc.M112.412379. Epub, 2012 Sep 25. PMID:23012356 doi:http://dx.doi.org/10.1074/jbc.M112.412379
5. ↑ Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T, Leavitt BR, Hayden MR, Timmusk T, Rigamonti D, Cattaneo E. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet. 2003 Sep;35(1):76-83. doi: 10.1038/ng1219. Epub 2003 Jul 27. PMID:12881722 doi:http://dx.doi.org/10.1038/ng1219
6. ↑ doi: https://dx.doi.org/10.1007/s11062-013-9341-1
7. ↑ Caviston JP, Ross JL, Antony SM, Tokito M, Holzbaur EL. Huntingtin facilitates dynein/dynactin-mediated vesicle transport. Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10045-50. doi:, 10.1073/pnas.0610628104. Epub 2007 Jun 4. PMID:17548833 doi:http://dx.doi.org/10.1073/pnas.0610628104
8. ↑ Godin JD, Colombo K, Molina-Calavita M, Keryer G, Zala D, Charrin BC, Dietrich P, Volvert ML, Guillemot F, Dragatsis I, Bellaiche Y, Saudou F, Nguyen L, Humbert S. Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron. 2010 Aug 12;67(3):392-406. doi: 10.1016/j.neuron.2010.06.027. PMID:20696378 doi:http://dx.doi.org/10.1016/j.neuron.2010.06.027
9. ↑ doi: https://dx.doi.org/10.1007/s11062-013-9341-1
10. ↑ Li W, Serpell LC, Carter WJ, Rubinsztein DC, Huntington JA. Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein. J Biol Chem. 2006 Jun 9;281(23):15916-22. doi: 10.1074/jbc.M511007200. Epub 2006 , Apr 4. PMID:16595690 doi:http://dx.doi.org/10.1074/jbc.M511007200
11. ↑ Neuwald AF, Hirano T. HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions. Genome Res. 2000 Oct;10(10):1445-52. doi: 10.1101/gr.147400. PMID:11042144 doi:http://dx.doi.org/10.1101/gr.147400
12. ↑ Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat Genet. 1996 Jun;13(2):196-202. doi: 10.1038/ng0696-196. PMID:8640226 doi:http://dx.doi.org/10.1038/ng0696-196
13. ↑ Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996 Nov 1;87(3):493-506. doi: 10.1016/s0092-8674(00)81369-0. PMID:8898202 doi:http://dx.doi.org/10.1016/s0092-8674(00)81369-0
14. ↑ 10.1016/s0092-8674(00)80464-x
15. ↑ O'Kusky JR, Nasir J, Cicchetti F, Parent A, Hayden MR. Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene. Brain Res. 1999 Feb 13;818(2):468-79. doi: 10.1016/s0006-8993(98)01312-2. PMID:10082833 doi:http://dx.doi.org/10.1016/s0006-8993(98)01312-2
16. ↑ Dragatsis I, Levine MS, Zeitlin S. Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet. 2000 Nov;26(3):300-6. doi: 10.1038/81593. PMID:11062468 doi:http://dx.doi.org/10.1038/81593
17. ↑ Guedes-Dias P, Pinho BR, Soares TR, de Proenca J, Duchen MR, Oliveira JM. Mitochondrial dynamics and quality control in Huntington's disease. Neurobiol Dis. 2016 Jun;90:51-7. doi: 10.1016/j.nbd.2015.09.008. Epub 2015 Sep, 24. PMID:26388396 doi:http://dx.doi.org/10.1016/j.nbd.2015.09.008
18. ↑ Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC. Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies. Cold Spring Harb Perspect Med. 2017 Jul 5;7(7). pii: cshperspect.a024240. doi:, 10.1101/cshperspect.a024240. PMID:27940602 doi:http://dx.doi.org/10.1101/cshperspect.a024240
19. ↑ Ochaba J, Lukacsovich T, Csikos G, Zheng S, Margulis J, Salazar L, Mao K, Lau AL, Yeung SY, Humbert S, Saudou F, Klionsky DJ, Finkbeiner S, Zeitlin SO, Marsh JL, Housman DE, Thompson LM, Steffan JS. Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16889-94. doi:, 10.1073/pnas.1420103111. Epub 2014 Nov 10. PMID:25385587 doi:http://dx.doi.org/10.1073/pnas.1420103111
20. ↑ Rui YN, Xu Z, Patel B, Cuervo AM, Zhang S. HTT/Huntingtin in selective autophagy and Huntington disease: A foe or a friend within? Autophagy. 2015;11(5):858-60. doi: 10.1080/15548627.2015.1039219. PMID:25985010 doi:http://dx.doi.org/10.1080/15548627.2015.1039219
21. ↑ doi: https://dx.doi.org/10.1101/330001